Description
Classic Lectures in Pathology: What You Need to Know – Breast Pathology 2025
Format: Expert Video Lectures + PDF Slides
Accreditation: CME Certified
Released: 2025
Category: Breast Pathology | Diagnostic Updates | Core Biopsies | Immunohistochemistry
Course Overview
Classic Lectures in Pathology: Breast Pathology 2025 delivers a practical, high-yield review of diagnostic breast pathology designed for everyday surgical pathology practice. Covering a broad range of both common and diagnostically challenging lesions, this expert-led course emphasizes accurate interpretation, classification, and reporting of both benign and malignant breast disease—particularly within the context of core needle biopsy specimens.
Whether you’re managing papillary lesions, triple-negative carcinoma, or post-neoadjuvant therapy cases, the faculty will guide you through modern pitfalls, practical pearls, and cutting-edge updates in ER/PR/HER2 testing, AJCC staging, and molecular classification.
Educational Objectives
Upon completing this CME activity, participants will be able to:
Classify benign and atypical proliferative lesions with diagnostic confidence
Apply molecular subclassification and predictive marker testing (ER, PR, HER2) in breast cancer management
Distinguish between reactive, inflammatory, and neoplastic breast conditions
Review updated AJCC breast cancer staging guidelines and their clinical impact
Understand the diagnostic nuances of post-treatment specimens
Navigate the complexity of papillary and spindle cell lesions
Lecture Topics & Faculty
A Practical Approach to Challenging Intraductal Proliferations – Andrew P. Sciallis, MD
Benign Breast Disease: Atypical Proliferative Lesions – David G. Hicks, MD
Papillary Lesions of the Breast: An Update – Andrew P. Sciallis, MD
Challenging Breast Pathology Cases – David G. Hicks, MD
Breast Core Needle Biopsies: Pitfalls and Pearls – Hannah Y. Wen, MD, PhD
ER and HER2 Testing: Current Issues and Controversies – David G. Hicks, MD
Lobular Carcinoma In-Situ & Problematic In-Situ Lesions – Stuart J. Schnitt, MD
Immunohistochemistry in Breast Lesion Diagnosis – David G. Hicks, MD
Reporting Post-Neoadjuvant Therapy Specimens – Carmen Gomez-Fernandez, MD
Myoepithelial & Epithelial-Myoepithelial Lesions – Stuart J. Schnitt, MD
Recurrent and Metastatic Breast Carcinoma – Patrick McIntire, MD
Problematic Papillary Tumors – Raza Hoda, MD
Prognostic & Predictive Markers in Breast Cancer – Hannah Y. Wen, MD, PhD
Triple-Negative Breast Carcinomas with Good Prognoses – Raza Hoda, MD
Spindle Cell Lesions of the Breast – Andrew P. Sciallis, MD
Post-Neoadjuvant Specimen Challenges – Stuart J. Schnitt, MD
Spectrum of Triple Negative Breast Cancer – Hannah Y. Wen, MD, PhD
Traditional & Emerging Prognostic Markers – David G. Hicks, MD
Ideal For
General Surgical Pathologists
Breast Pathologists
Residents & Fellows in Anatomic Pathology
Oncologic & Diagnostic Practitioners
Elevate your diagnostic accuracy with insights from the most respected experts in breast pathology. This course bridges foundational knowledge with cutting-edge practice — making it ideal for both clinical routine and complex case interpretation.
